RxDoctor Payments Data

Leon McLean, MD

Gastroenterology · Derry, NHNPI 1457495806

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $139,129 of the $170,777 with a category attached, or 81.5%. 16 manufacturers reported payments, led by AbbVie at 58.0% of the total. 2025 is the largest year on record at $44,904, 3.5 times the $12,827 reported in 2019. Among gastroenterology clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$170,777in general payments, 2019–2025

Across 315 payments — averaging $542.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$99K
  • E.r. Squibb & Sons, L.L.C.$46K
  • Johnson & Johnson$17K
  • Pfizer$6K
  • Bristol Myers Squibb$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$389
  • plus $622 from 10 others

What the payments were for

  • Consulting fees$8,1605%
  • Speaking & faculty fees$139,12981%
  • Travel & lodging$15,8969%
  • Food & beverage$7,5544%
  • Education$380%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$170,777 in reported general payments places this provider in the 95th percentile of 91 gastroenterology providers in New Hampshire.

See all gastroenterology providers in New Hampshire

Medicare billing

Part B allowed, 2024
$133,109
Medicare patients
556
Services billed
957

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab12$121,654
Humira PenAdalimumab12$81,674
Mesalamine11$16,412
Pantoprazole Sodium152$2,468
Balsalazide Disodium14$1,677
Omeprazole59$854
Esomeprazole Magnesium23$634
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl49$624
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl32$411
Famotidine33$267

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Derry

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →